Daniel Starks - St Jude Insider

St Jude Medical -- USA Stock  

USD 80.82  0.13  0.16%

Executive Chairman

Mr. Daniel J. Starks was appointed as Executive Chairman of the Board of St. Jude Medical Inc. effective January 1 2016. He was President Chief Executive Officer of St. Jude Medical Inc. He has served as Chief Operating Officer of St. Jude Medical from January 2001 to May 2004. From April 1998 to February 2001 President and Chief Executive Officer of the Cardiac Rhythm Management Division of St. Jude Medical. Previously Chief Executive Officer and President Daig Corporationrationration
Age: 60  Chairman Since 2016      
651 756-3301  www.sjm.com

Daniel Starks Latest Insider Activity

Management Efficiency

The company has Return on Asset of 0.08 % which means that on every $100 spent on asset it made $0.08 of profit. This is way below average.
The company has 6.39 B in debt with debt to equity (D/E) ratio of 1.29 which is OK given its current industry classification. St Jude Medical has Current Ratio of 1.89 which is typical for the industry and considered as normal.

Similar Executives

Entity Summary

St. Jude Medical, Inc., together with its subsidiaries, develops, manufactures, and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide. St Jude Medical (STJ) is traded on New York Stock Exchange in USA. It is located in MINNESOTA, U.S.A and employs 18,000 people. St Jude is listed under Medical Equipment category by Fama And French industry classification.

St Jude Medical Leadership Team

David Lamb, Managing Director
Baroness Wheatcroft, Director
Ian Gascoigne, Managing Director
John Heinmiller, EVP
Tony Dunk, Director
Denis Gestin, President
Craig Gentle, CFO
Stephan Widensohler, Director
Donald Zurbay, CFO
Lisa Andrade, Executive
Wendy Yarno, Director
Iain Cornish, Director
Richard Devenuti, Director
Sarah Bates, Chairman
Jeffrey Dallager, President
Joel Becker, President
Stuart Essig, Director
Andrew Croft, Director
Barbara Hill, Director
David Bellamy, Director
Roger Yates, Director
John Brown, Director
Daniel Starks, Chairman
Eric Fain, President
Elizabeth Kelly, Executive
Rachel Ellingson, President
Mark Carlson, President
Paul Bae, President
Michael Rousseau, CEO
Mark Murphy, VP
Scott Thome, President
Michael Rocca, Director
Simon Jeffreys, Director
Jeff Fecho, President
Jason Zellers, President
J Weigelt, Director
David Dvorak, Director
Stefan Widensohler, Director

Stock Performance Indicators

Current Sentiment - STJ

St Jude Medical Investor Sentiment
Greater number of Macroaxis users are at this time bullish on St Jude Medical. What is your outlook on investing in St Jude Medical? Are you bullish or bearish?
98% Bullish
2% Bearish

Trending Equities

Currently Active Assets on Macroaxis
Purchased over 200 shares of
3 hours ago
Traded for 10.96
Purchased over 30 shares of
3 hours ago
Traded for 96.11
Purchased over 70 shares of
3 hours ago
Traded for 37.77
Purchased over 100 shares of
3 hours ago
Traded for 30.6
Purchased over 20 shares of
3 hours ago
Traded for 124.06
Purchased over 100 shares of
3 hours ago
Traded for 23.82
Also please take a look at World Market Map. Please also try Piotroski F Score module to get piotroski f score based on binary analysis strategy of nine different fundamentals.